STOCK TITAN

Sponsor funds Aimei Health (NASDAQ: AFJK) one-month SPAC extension

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Aimei Health Technology Co., Ltd extended the deadline to complete its initial business combination by one month, moving the termination date from May 6, 2026 to June 6, 2026. To fund this extension, the company deposited an Extension Payment of $34,330.96 into its trust account for public shareholders.

In connection with this move, Aimei Health issued a zero‑interest Promissory Note for $34,330.96 to its sponsor, Aimei Health Ltd, and United Hydrogen Group Inc., with each contributing $17,165.48. The note is due upon completion of the business combination with United Hydrogen and can be converted into private units at $10.00 per unit immediately before closing.

Positive

  • None.

Negative

  • None.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Extension Payment $34,330.96 Deposited into trust account for one-month extension
Per-share extension rate $0.033 per public share Monthly extension cost per outstanding public share
Maximum monthly extension cap $80,000 Cap for all outstanding public shares per month
Sponsor contribution $17,165.48 Amount contributed by Aimei Health Ltd to Extension Payment
United Hydrogen contribution $17,165.48 Amount contributed by United Hydrogen Group Inc.
Unit conversion price $10.00 per unit Price to convert Promissory Note into private units
Extension sequence Eighteenth extension Number of extensions under Articles of Association
Extended termination date June 6, 2026 New deadline to complete initial business combination
Extension Payment financial
"An aggregate of $34,330.96 (the “Extension Payment”) has been deposited"
trust account financial
"deposited into the trust account of Aimei Health Technology Co., Ltd"
A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.
Promissory Note financial
"the Company issued, on May 6, 2026, an unsecured promissory note"
A promissory note is a written IOU in which one party promises to pay a specific sum, often with interest, to another party by a set date or on demand. Investors care because it functions like a loan: it creates a legal claim on future cash flows, carries credit and timing risk, and can affect valuation or liquidity—think of it as a formal, tradable promise to be repaid that can be assessed like any other debt investment.
business combination financial
"to consummate its initial business combination by one month"
A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.
private units financial
"convert the Promissory Note, in whole or in part, into private units"
Amended and Restated Articles of Association regulatory
"The Extension is the eighteenth extension permitted under the Amended and Restated Articles of Association"
false 0001979005 0001979005 2026-05-06 2026-05-06 0001979005 AFJK:OrdinarySharesParValue0.0001PerShareMember 2026-05-06 2026-05-06 0001979005 AFJK:RightsExchangeableIntoOnefifthOfOneOrdinaryShareMember 2026-05-06 2026-05-06 0001979005 AFJK:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2026-05-06 2026-05-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

May 6, 2026

Date of Report (Date of earliest event reported)

 

AIMEI HEALTH TECHNOLOGY CO., LTD

(Exact Name of Registrant as Specified in its Charter)

 

Cayman Islands   001-41880   N/A

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

10 East 53rd Street, Suite 3001

New York, NY

  10022
(Address of Principal Executive Offices)   (Zip Code)

 

86-13758131392

Registrant’s telephone number, including area code

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol(s)   Name of each exchange on which registered
Ordinary Shares, par value $0.0001 per share   AFJK   The Nasdaq Stock Market LLC
Rights, exchangeable into one-fifth of one Ordinary Share   AFJKR   The Nasdaq Stock Market LLC
Units, each consisting of one Ordinary Share and one Right   AFJKU   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

Extension of the Termination Date

 

An aggregate of $34,330.96 (the “Extension Payment”) has been deposited into the trust account of Aimei Health Technology Co., Ltd (the “Company”) for its public shareholders, representing the lessor of (i) $80,000 for all outstanding public shares and (ii) $0.033 for each outstanding public share for each monthly extension, which enables the Company to further extend the period of time it has to consummate its initial business combination by one month (the “Extension”) from May 6, 2026 to June 6, 2026 (the “Termination Date”). The Extension is the eighteenth extension permitted under the Amended and Restated Articles of Association of the Company currently in effect.

 

Promissory Note

 

In connection with the Extension, the Company issued, on May 6, 2026, an unsecured promissory note in the total principal amount of $34,330.96 (the “Promissory Note”) to Aimei Health Ltd, a Cayman Islands exempted company (the “Sponsor”) and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“United Hydrogen,” and together with the Sponsor, the “Payees”). The amount was equally divided between the Payees, with each contributing $17,165.48, to fund the Extension Payment. The Promissory Note does not bear interest and the principal thereunder becomes due and payable upon the date on which the Company consummates a business combination with United Hydrogen (the “Business Combination”). The Payees have the right, but not the obligation, to convert the Promissory Note, in whole or in part, into private units of the Company, at a price of $10.00 per unit, each consisting of one ordinary share and one right to receive one-fifth (1/5) of one ordinary share of the Company, immediately prior to the consummation of the Business Combination, by providing the Company with written notices of their intention to convert the Promissory Note at least two business days prior to the closing of the Business Combination.

 

The foregoing description of the Promissory Note is not complete and is qualified in its entirety by reference to the text of such document, which is filed as Exhibit 10.1 hereto and which is incorporated herein by reference.

 

Item 9.01 Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
10.1   Promissory Note, dated May 6, 2026, by and among Aimei Health Technology Co., Ltd, Aimei Health Ltd, and United Hydrogen Group Inc.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 6, 2026

 

  Aimei Health Technology Co., Ltd
     
  By: /s/ Junheng Xie
  Name: Junheng Xie
  Title: Chief Executive Officer and Director
    (Principal Executive Officer)

 

 

 

FAQ

What did Aimei Health Technology (AFJK) announce in this 8-K filing?

Aimei Health Technology extended its business combination deadline by one month, from May 6, 2026 to June 6, 2026, by depositing $34,330.96 into its trust account and issuing a corresponding zero‑interest promissory note to its sponsor and United Hydrogen Group Inc.

How much did Aimei Health (AFJK) deposit for the SPAC extension?

Aimei Health deposited $34,330.96 as an Extension Payment into its trust account. This amount represents the lesser of $80,000 for all public shares or $0.033 per outstanding public share for the one‑month extension to June 6, 2026.

Who funded the Aimei Health (AFJK) SPAC extension payment?

The Extension Payment was funded equally by Aimei Health Ltd, the sponsor, and United Hydrogen Group Inc. Each party contributed $17,165.48, and Aimei Health issued a single zero‑interest promissory note for $34,330.96 in their favor, tied to the planned business combination.

What are the key terms of Aimei Health’s $34,330.96 Promissory Note?

The Promissory Note for $34,330.96 bears no interest and becomes payable when Aimei Health completes its business combination with United Hydrogen. The payees may convert it into private units at $10.00 per unit immediately before closing, each unit including one share and one‑fifth share right.

How many times has Aimei Health extended its SPAC deadline?

The company stated this one‑month extension to June 6, 2026 is its eighteenth extension under its Amended and Restated Articles of Association. Each extension is funded through payments into the trust account for the benefit of public shareholders.

What securities can the Aimei Health promissory note convert into?

The promissory note can be converted into private units of Aimei Health at $10.00 per unit. Each private unit consists of one ordinary share and one right to receive one‑fifth of one additional ordinary share immediately prior to consummating the business combination.

Filing Exhibits & Attachments

5 documents